GlobalMed Telemedicine

globalmed.com

Founded in early 2002 in Scottsdale, Arizona, GlobalMed is a real-time healthcare delivery system company that deploys state-of-the-art hardware, software, and service solutions that enable leading healthcare professionals to be more effective in providing patient care and more efficient in managing patient information. As the worldwide leader in telemedicine and only vertically-integrated provider, GlobalMed technologies enable more than 3 million telehealth consults annually and are deployed in more than 55 countries around the world. Our evidence-based solutions include telemedicine stations, examination cameras, connected medical devices, video conferencing tools, and software that allow for the dynamic collaboration of healthcare professionals at remote locations across the globe. Partnering with leading medical groups, healthcare enterprises, and government agencies has led to our unparalleled expertise in designing sustainable, integrated connected health programs that deliver best-in-class patient care.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

CELL AND GENE THERAPY

SPHERE FLUIDICS CLOSES A $40 MILLION FUNDING ROUND LED BY SOFINNOVA PARTNERS AND REDMILE GROUP

Sphere Fluidics | October 29, 2021

news image

Sphere Fluidics, a company that has developed and is commercialising single cell analysis systems underpinned by its proprietary picodroplet technology, announced today that it has closed a $40 million investment round. The round was led by Sofinnova Partner and Redmile Group investing on equal terms. Sphere Fluidics will use the funding to enable the expansion of the Company’s international sales activities in key markets and improving its support for customers. Furthermore...

Read More

INDUSTRIAL IMPACT, MEDICAL

SYNTHEGO INTRODUCES CRISPR DISCOVERY PARTNERS TO STREAMLINE CRISPR-DRIVEN DRUG DISCOVERY RESEARCH

Synthego | March 17, 2023

news image

Synthego Corp., a leading genome engineering solutions provider, announced today the launch of its service partner ecosystem, CRISPR Discovery Partners, designed to accelerate drug discovery by providing a seamless research workflow from CRISPR editing to phenotypic data and downstream services. The ecosystem brings together high-value partners including Arctoris, BrainXell, Curia, PhenoVista, and Pluristyx to offer a coordinated solution for CRISPR-driven drug discovery. The CR...

Read More

BON NATURAL LIFE LIMITED INTRODUCES NEW POWDER DRINK FOR ANTI-H. PYLORI AND DIGESTIVE HEALTH

Bon Natural | June 17, 2022

news image

Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, today announced that it has launched a new cruciferous vegetable based probiotic powder drink that could potentially inhibit the proliferation of Helicobacter pylori and help regulate the digestive system. The powder drink is the first proprietary product of BON's cruciferous vegetable based health supp...

Read More

GENAPSYS RAISES $75M TO BRING ITS TABLETOP DNA SEQUENCER TO ASIA AMID CORONAVIRUS OUTBREAK

FierceBiotech | February 06, 2020

news image

Just months after collecting $90 million to support the launch of its compact DNA sequencing hardware, GenapSys has raised another $75 million to finance its global expansion with its eyes set on the Asia-Pacific market and the expanding coronavirus outbreak. The company’s high-throughput sequencer—which sits on a tabletop and weighs less than 10 pounds—is being launched in South Korea, Singapore, Japan and China as part of more than 25 recently inked distribution deals....

Read More
news image

CELL AND GENE THERAPY

SPHERE FLUIDICS CLOSES A $40 MILLION FUNDING ROUND LED BY SOFINNOVA PARTNERS AND REDMILE GROUP

Sphere Fluidics | October 29, 2021

Sphere Fluidics, a company that has developed and is commercialising single cell analysis systems underpinned by its proprietary picodroplet technology, announced today that it has closed a $40 million investment round. The round was led by Sofinnova Partner and Redmile Group investing on equal terms. Sphere Fluidics will use the funding to enable the expansion of the Company’s international sales activities in key markets and improving its support for customers. Furthermore...

Read More
news image

INDUSTRIAL IMPACT, MEDICAL

SYNTHEGO INTRODUCES CRISPR DISCOVERY PARTNERS TO STREAMLINE CRISPR-DRIVEN DRUG DISCOVERY RESEARCH

Synthego | March 17, 2023

Synthego Corp., a leading genome engineering solutions provider, announced today the launch of its service partner ecosystem, CRISPR Discovery Partners, designed to accelerate drug discovery by providing a seamless research workflow from CRISPR editing to phenotypic data and downstream services. The ecosystem brings together high-value partners including Arctoris, BrainXell, Curia, PhenoVista, and Pluristyx to offer a coordinated solution for CRISPR-driven drug discovery. The CR...

Read More
news image

BON NATURAL LIFE LIMITED INTRODUCES NEW POWDER DRINK FOR ANTI-H. PYLORI AND DIGESTIVE HEALTH

Bon Natural | June 17, 2022

Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, today announced that it has launched a new cruciferous vegetable based probiotic powder drink that could potentially inhibit the proliferation of Helicobacter pylori and help regulate the digestive system. The powder drink is the first proprietary product of BON's cruciferous vegetable based health supp...

Read More
news image

GENAPSYS RAISES $75M TO BRING ITS TABLETOP DNA SEQUENCER TO ASIA AMID CORONAVIRUS OUTBREAK

FierceBiotech | February 06, 2020

Just months after collecting $90 million to support the launch of its compact DNA sequencing hardware, GenapSys has raised another $75 million to finance its global expansion with its eyes set on the Asia-Pacific market and the expanding coronavirus outbreak. The company’s high-throughput sequencer—which sits on a tabletop and weighs less than 10 pounds—is being launched in South Korea, Singapore, Japan and China as part of more than 25 recently inked distribution deals....

Read More